ISAT- Intelligent sensing in ADHD trial
Research type
Research Study
Full title
Intelligent Sensing in ADHD Trial
IRAS ID
359126
Contact name
Mohsen Naqvi
Contact email
Sponsor organisation
CUMBRIA NORTHUMBERLAND TYNE AND WEAR NHSFT
Duration of Study in the UK
5 years, 0 months, 30 days
Research summary
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition characterized by inappropriate levels of inattention, hyperactivity, and impulsivity, which manifest in various scenarios. Longitudinal studies show that 60% to 90% of children with ADHD continue to exhibit symptoms and impairments into adulthood . According to WHO, the global prevalence of ADHD in children is around 5.29% and adults is 3%. ADHD. Untreated ADHD could cause significant impairment in multiple areas including education, employment, interpersonal relationships, legal issues, road traffic accidents, substance misuse etc. Moreover, a study in 2018 estimated the economic burden of ADHD-related unemployment at $66.8 billion, with productivity losses of $28.8 billion and health service costs at $14.8 billion.
There has been a significant increase in awareness about ADHD, which has led to increasing referrals. The referral rates have increased exponentially leading to very long waiting lists- well over a decade. This delay in diagnosis leads to suffering and impairments as mentioned above. Early diagnosis and treatment would lead to a better a quality of life and reduction of the adverse outcomes from ADHD.
We are developing a non invasive AI technology using data captured from audio, video and actigraphy ( movement measurements) to enable early diagnosis and monitoring. This AI technology would bring objectivity and accuracy to the diagnosis as well.REC name
London - Westminster Research Ethics Committee
REC reference
25/PR/1408
Date of REC Opinion
1 Dec 2025
REC opinion
Further Information Favourable Opinion